Evaluation of Erythropoietin Stimulating Agents (ESA) and Their Effect on Blood Optimization for Cardiac Surgery.

Kristina S Gill; Abigail D Antigua; A Kacee Barnett; Aubrey J Hall; Charles T Klodell

doi:10.1177/0897190020969274

Evaluation of Erythropoietin Stimulating Agents (ESA) and Their Effect on Blood Optimization for Cardiac Surgery.

Kristina S Gill
, Abigail D Antigua
, A Kacee Barnett
, Aubrey J Hall
, Charles T Klodell

Department of Pharmacy, 23696North Florida Regional Medical Center, Gainesville, FL, USA.
Department of Pharmacy, Cardiovascular Surgery and Medicine, 23696North Florida Regional Medical Center, Gainesville, FL, USA.
Critical Care, Department of Pharmacy, 23696North Florida Regional Medical Center, Gainesville, FL, USA.
Cardiothoracic Surgery, 23696North Florida Regional Medical Center, Florida Heart and Lung Institute, Gainesville, FL, USA.
Cardiovascular Intensive Care Unit, 23696North Florida Regional Medical Center, Florida Heart and Lung Institute, Gainesville, FL, USA.

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Pharmacy Practice
DOIs	https://doi.org/10.1177/0897190020969274
State	Published - Nov 6 2020
Externally published	Yes

Disciplines

Medicine and Health Sciences
Anesthesiology

Access to Document

10.1177/0897190020969274License: Unspecified

Cite this

@article{2b0820d08cd84855a085a8bc8e57a4c2,

title = "Evaluation of Erythropoietin Stimulating Agents (ESA) and Their Effect on Blood Optimization for Cardiac Surgery.",

author = "Gill, \{Kristina S\} and Antigua, \{Abigail D\} and Barnett, \{A Kacee\} and Hall, \{Aubrey J\} and Klodell, \{Charles T\}",

note = "Background Cardiovascular surgeries increase the risk of receiving blood transfusions. Erythropoietin stimulating agents (ESAs) have been used to decrease the transfusion rate. The objective of this study was to evaluate the administration of blood products post-cardiothoracic surgery after receiving ESAs. Methods This is a single-center, retrospective cohort study.",

year = "2020",

month = nov,

day = "6",

doi = "10.1177/0897190020969274",

language = "American English",

journal = "Journal of Pharmacy Practice",

}

TY - JOUR

T1 - Evaluation of Erythropoietin Stimulating Agents (ESA) and Their Effect on Blood Optimization for Cardiac Surgery.

AU - Gill, Kristina S

AU - Antigua, Abigail D

AU - Barnett, A Kacee

AU - Hall, Aubrey J

AU - Klodell, Charles T

N1 - Background Cardiovascular surgeries increase the risk of receiving blood transfusions. Erythropoietin stimulating agents (ESAs) have been used to decrease the transfusion rate. The objective of this study was to evaluate the administration of blood products post-cardiothoracic surgery after receiving ESAs. Methods This is a single-center, retrospective cohort study.

PY - 2020/11/6

Y1 - 2020/11/6

UR - https://europepmc.org/article/MED/33153395

U2 - 10.1177/0897190020969274

DO - 10.1177/0897190020969274

M3 - Article

JO - Journal of Pharmacy Practice

JF - Journal of Pharmacy Practice

ER -

Evaluation of Erythropoietin Stimulating Agents (ESA) and Their Effect on Blood Optimization for Cardiac Surgery.

Disciplines

Access to Document

Other files and links

Cite this